A clinical study on the effect of patolyadi ghrita akshitarpana & shilajit rasayana in diabetic retinopathy

Recent data suggests that diabetic retinopathy is the leading cause of hlindness in diabetis mellitus. It is estimated that there are approximately 33 million adults with diabetes in India. Thin number is likely to increase to 57.2 million by the year 2030.

Treatment for diabetic retinopathy is not cost-effective and though intra vitreal injections play a key-role in the management of DR its very difficult due to nature of progression of disease.

A study revealed that the prevalence of DR among persons with diabetes was 16.9% and the  prevalence of mild retinopathy was 11.8% It is evident that 90% of patients with DM for 15-20 years will have some of the retinopathy changes like aneurysm IRMA etc., Although modern medical science has made tremendous and remarkable progress and advance in the field of ophthalmology in recent times, the importance of ayurvedic treatment in the diseases of eyes cannot be ignored owing to the above mentioned pitfalls of the modern therapy. Ayurveda ocular therapies known as kriya kalpa has proven benefit on ocular pathologies.

Regardless of the method used to detect DR, the prevalence of DR among persons with diabetes ranged from 10% to 30.4%. A study reported a prevalence of 16.9%, which is comparable to other studies using plasma glucose as the criteria for DM; studies relying on self-report of DM had reported a higher prevalence of DM Prevalence of DR was higher in the urban examined population than in the rural population at 20.7% and 15.5% respectively.

Add reaction